Moderna reports surprise profit on higher-than-expected COVID vaccine …
Moderna still expects to make less from COVID vaccine sales this year than it did in 2023, however, and reaffirmed its 2024 sales forecast of $3 billion to $3.5 billion. The company brought in ...
Moderna Advances Multiple Vaccine Programs to Late-Stage …
Mar 27, 2024 · Moderna is advancing five vaccine candidates against viruses that cause latent infections, all of which are in clinical trials. When latent, a virus is present in the body but exists in a resting state, typically without causing any noticeable symptoms.
News Details - Moderna
Mar 26, 2024 · The NEXTCove clinical trial is a randomized, observer-blind, active-controlled study of approximately 11,400 individuals aged 12 years and older in the United States, United Kingdom and Canada. mRNA-1283 was found to have a similar safety profile to Moderna's approved COVID-19 vaccines.
FDA Takes Action on Updated mRNA COVID-19 Vaccines to …
FDA approved and authorized for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious ...
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
FDA approved and authorized for emergency use updated mRNA COVID-19 vaccines (2024-2025 formula) to more closely target currently circulating variants to prevent COVID-19 and to provide better...
Moderna Clinical Trial Data Confirm Its Updated Covid-19 Vaccine ...
Sep 6, 2023 · Clinical trial data from research assay confirmed Moderna's updated COVID-19 vaccine showed an 8.7 to 11-fold increase in neutralizing antibodies against circulating variants, including BA.2.86, EG.5, and FL.1.5.1 variants.
The FDA just approved the new Covid vaccine: When to get it ... - NBC News
Aug 22, 2024 · Pfizer, Moderna and Novavax are charging up to $150 per dose for a Covid vaccine, according to data from the Centers for Medicare and Medicaid Services.
The Moderna COVID-19 (mRNA-1273) vaccine: what you need …
Aug 18, 2022 · The Moderna vaccine after two doses and a first booster dose has been shown to have very high effectiveness against severe disease, hospitalizations and death, and modest effectiveness against symptomatic illness.
Novavax COVID shots offer a third option, along with Pfizer and Moderna …
Aug 22, 2024 · The Food and Drug Administration has greenlighted three updated vaccines — the Pfizer-BioNTech and Moderna shots, and now a third one from Novavax, which was just authorized by the FDA on...
Moderna posts surprise profit as Covid vaccine sales impress, …
6 days ago · Moderna is developing a stand-alone flu shot, a personalized cancer vaccine with Merck and shots for latent viruses, among other products. Cost of sales for the third quarter was $514 million ...